Daniel Ahn, DO | Authors

August 20, 2021

This article reviews MRD and decision-making in early-stage colorectal cancer and includes insights from Christopher Lieu, MD, of the University of Colorado School of Medicine in Denver, and Daniel Ahn, DO, of the Mayo Clinic in Phoenix, AZ.

June 25, 2021

Dr. Daniel Ahn discusses the implications of postoperative ctDNA testing for decision-making in early stage CRC.

March 26, 2021

Christopher Lieu, MD, discusses the standard of care for genomic profiling in early stage CRC.